Abbott Introduces Libre Assist, an AI Tool for Predicting Meal Impact on Blood Sugar
At CES 2026, Abbott introduced Libre Assist, a groundbreaking tool designed to assist individuals with diabetes in managing their blood sugar levels through artificial intelligence. By simply taking a photo of their meal, users can receive predictions regarding how their food choices will affect their glucose levels. This innovative feature is a significant step in Abbott's ongoing commitment to integrating algorithmic AI into its FreeStyle Libre continuous glucose monitoring system, which has been in development for over a decade.
The Libre Assist tool operates similarly to having a nutritionist at one’s fingertips. Users can point their camera at their food, and the system employs image recognition technology to evaluate the meal, assigning it a rating on a scale of green, yellow, or orange based on the anticipated glucose impact. In addition to this visual assessment, Libre Assist offers personalized dietary recommendations, transforming complex data into actionable insights before the user even takes a bite.
Abbott has long been a pioneer in the realm of diabetes care, with the FreeStyle Libre platform serving as its flagship continuous glucose monitoring device. This device, worn as a small sensor on the back of the arm, continuously tracks glucose levels, and with the introduction of Libre Assist, it expands its functionality from merely monitoring to actively aiding in meal planning.
While Abbott has established partnerships with companies like Medtronic and Novo Nordisk in diabetes care, there is no indication of collaboration with Google for this AI initiative. The technology behind Libre Assist is reportedly developed entirely in-house by Abbott.
For the estimated 537 million adults globally living with diabetes, the critical question remains: will the ability to photograph meals and receive glucose predictions lead to improved dietary choices? If Libre Assist can effectively guide users toward healthier eating habits before their blood sugar levels rise, it could represent a significant advancement in diabetes management, translating years of algorithmic research into practical, everyday applications for users.




